New selective PAD4 inhibitors binding a calcium-deficient sort of the PAD4 enzyme have validated the important enzymatic position of human and mouse PAD4 in equally histone citrullination and neutrophil extracellular trap formation for, to our information, the first time. The therapeutic potential of PAD4 inhibitors can now be explored. Calculate https://geraldh665xju9.signalwiki.com/user